These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania. Milienne-Petiot M; Geyer MA; Arnt J; Young JW Psychopharmacology (Berl); 2017 Mar; 234(6):1017-1028. PubMed ID: 28160035 [TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter is downregulated and its association with chaperone protein Hsc70 is enhanced by activation of dopamine D Chang PK; Chien KY; Chen JC Brain Res Bull; 2020 Dec; 165():263-271. PubMed ID: 33049353 [TBL] [Abstract][Full Text] [Related]
14. Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems. Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Di Marzo V; Drago F Pharmacol Res; 2010 Jun; 61(6):531-6. PubMed ID: 20149873 [TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9-Mediated Intersectional Knockout of Glycogen Synthase Kinase 3β in D2 Receptor-Expressing Medial Prefrontal Cortex Neurons Reveals Contributions to Emotional Regulation. Khlghatyan J; Beaulieu JM CRISPR J; 2020 Jun; 3(3):198-210. PubMed ID: 32584144 [TBL] [Abstract][Full Text] [Related]
16. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA Pharmacol Biochem Behav; 2010 Jul; 96(1):7-15. PubMed ID: 20363246 [TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder. Lavoie J; Hébert M; Beaulieu JM Biol Psychiatry; 2014 Jul; 76(2):93-100. PubMed ID: 24138923 [TBL] [Abstract][Full Text] [Related]
18. Deletion of Glycogen Synthase Kinase-3β in D Li YC; Panikker P; Xing B; Yang SS; Alexandropoulos C; McEachern EP; Akumuo R; Zhao E; Gulchina Y; Pletnikov MV; Urs NM; Caron MG; Elefant F; Gao WJ Biol Psychiatry; 2020 Apr; 87(8):745-755. PubMed ID: 31892408 [TBL] [Abstract][Full Text] [Related]
19. In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder. Barth V; Need AB; Tzavara ET; Giros B; Overshiner C; Gleason SD; Wade M; Johansson AM; Perry K; Nomikos GG; Witkin JM J Pharmacol Exp Ther; 2013 Feb; 344(2):501-10. PubMed ID: 23197772 [TBL] [Abstract][Full Text] [Related]
20. Microglial activation contributes to depressive-like behavior in dopamine D3 receptor knockout mice. Wang J; Lai S; Li G; Zhou T; Wang B; Cao F; Chen T; Zhang X; Chen Y Brain Behav Immun; 2020 Jan; 83():226-238. PubMed ID: 31626970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]